Cogent Biosciences Inc (COGT)
8.91
-0.74
(-7.67%)
USD |
NASDAQ |
Nov 15, 16:00
9.27
+0.36
(+4.04%)
After-Hours: 18:56
Cogent Biosciences Total Assets (Quarterly): 429.94M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 429.94M |
| March 31, 2024 | 476.11M |
| December 31, 2023 | 313.44M |
| September 30, 2023 | 355.45M |
| June 30, 2023 | 392.37M |
| March 31, 2023 | 263.20M |
| December 31, 2022 | 300.81M |
| September 30, 2022 | 331.56M |
| June 30, 2022 | 366.05M |
| March 31, 2022 | 206.87M |
| December 31, 2021 | 232.09M |
| September 30, 2021 | 215.38M |
| June 30, 2021 | 228.52M |
| Date | Value |
|---|---|
| March 31, 2021 | 237.61M |
| December 31, 2020 | 250.92M |
| September 30, 2020 | 139.87M |
| June 30, 2020 | 31.06M |
| March 31, 2020 | 38.94M |
| December 31, 2019 | 49.42M |
| September 30, 2019 | 57.88M |
| June 30, 2019 | 69.31M |
| December 31, 2018 | 85.93M |
| September 30, 2018 | 94.79M |
| June 30, 2018 | 102.72M |
| March 31, 2018 | 43.42M |
| December 31, 2017 | 49.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
31.06M
Minimum
Jun 2020
476.11M
Maximum
Mar 2024
255.77M
Average
250.92M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 56.71M |
| Shareholders Equity (Quarterly) | 373.22M |